Akoya Biosciences
About:
Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.
Website: https://www.akoyabio.com/
Twitter/X: AkoyaBio
Top Investors: Innovatus Capital Partners, Telegraph Hill Partners, Piper Jaffray Merchant Banking, Thomas Schnettler
Description:
Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.
$127M
$50M to $100M
Marlborough, Massachusetts, United States
2015-01-01
info(AT)akoyabio.com
Garry Nolan, Nikolay Samusik, Yury Goltsev
251-500
2023-06-07
Public
© 2025 bioDAO.ai